Section
Solid organ transplant recipients exhibit heightened risk for HPV-associated anal dysplasia and cancer due to unique immunosuppressive alterations. A transplant-tailored model of mucosal immune dysfunction elucidates mechanisms driving pers
This study analyzes healthcare usage up to 12 months after COVID-19 infection, revealing prolonged increased utilization—especially among hospitalized patients—highlighting ongoing care needs for survivors.
Health authorities in New York State have confirmed the region’s first case of Bourbon virus , a rare and potentially deadly tick-borne infection for
This study evaluates the impact of Long COVID on pregnancy outcomes, finding no significant risk for preterm birth but a potential association with hypertensive disorders, underscoring the need for further research.
This study elucidates distinct temporal patterns of posterior segment imaging features in ocular syphilis correlated with symptom duration and laboratory markers, enhancing diagnostic timing and clinical interpretation.
Following pivotal trial data demonstrating reduced infection and pancreatic fistula rates with piperacillin-tazobactam prophylaxis in pancreatoduodenectomy, adoption of broad-spectrum antibiotics increased significantly, particularly among
A 7-day perioperative sofosbuvir/velpatasvir prophylaxis in HCV-positive donor to HCV-negative recipient kidney transplants demonstrated sustained virologic response in over 92% of cases, with favorable 1-year graft survival and function.
A pooled analysis from 22 countries demonstrates that rotavirus vaccination is highly effective in preventing rotavirus-positive acute gastroenteritis deaths in children under five, underscoring the vaccine’s critical role in reducing
A 2-week-old neonate developed congenital tuberculosis despite an asymptomatic mother, illustrating diagnostic challenges and the need for heightened awareness of TB in pregnancy.
This longitudinal study characterizes symptom variability and outcomes of respiratory infections among young children, revealing age-specific severity patterns and notable differences between influenza A and B.
AHB-137, an antisense oligonucleotide targeting HBV mRNA, demonstrated safety, favorable pharmacokinetics, and rapid HBsAg reduction in healthy volunteers and chronic hepatitis B patients, supporting further clinical development.
This analysis of the ZEDS trial suggests that valacyclovir prophylaxis offers temporally localized protection against recurrent ocular inflammation in herpes zoster ophthalmicus, supporting one-year suppressive therapy despite non-significa
Extra-pulmonary tuberculosis survivors exhibit persistent lung function impairments and respiratory symptoms, highlighting the need for screening and management of post-TB lung disease beyond pulmonary TB cases.
A pioneering study shows that AI-enhanced ECG screening combined with epidemiological data can identify undiagnosed Chagas disease cases, improving early detection and care in endemic Brazil.
This review synthesizes evidence on the comprehensive economic impact of the 2025 New Mexico measles outbreak, emphasizing the high societal costs and critical role of vaccination-related public health interventions in outbreak control and
A multicenter prospective real-world study in China evaluated treatment outcomes of tinea capitis, highlighting itraconazole’s superior efficacy over terbinafine for certain fungal strains like Microsporum canis, informing optimized a
The SwissLEGIO score refines Legionella prediction in community-acquired pneumonia, enhancing specificity while maintaining high sensitivity, thereby optimizing microbiological testing and improving clinical management.
Adjuvant pegylated interferon following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B significantly increases HBsAg loss rates and reduces severe hepatic flares over three years compared to withdrawal alone.
The AFRI-c trial found no significant reduction in respiratory infection rates or staff absenteeism in care homes using HEPA filters during winter, highlighting the need to maintain established infection control measures.
This article reviews the accelerated evidence generation for anticoagulation in noncritically ill COVID-19 patients, highlighting how coordinated trials and data sharing influenced clinical guidelines and patient outcomes during the pandemi
